Screener
Summit Therapeutics SMMT Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current liabilities | 83,266 | 72,988 |
| Non-current liabilities: | ||
| Operating lease liabilities, net of current portion | 16,859 | 17,502 |
| Other non-current liabilities | 1,799 | 1,832 |
| Total liabilities | 101,924 | 92,322 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.01 par value, 20,000,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's other non-current liabilities?
- Summit Therapeutics (SMMT) reported other non-current liabilities of $1.8M in Q1 2026.
- How has Summit Therapeutics's other non-current liabilities changed year-over-year?
- Summit Therapeutics's other non-current liabilities increased by 5.3% year-over-year, from $1.71M to $1.8M.
- What is the long-term trend for Summit Therapeutics's other non-current liabilities?
- Over 5 years (2020 to 2025), Summit Therapeutics's other non-current liabilities has grown at a -6.1% compound annual growth rate (CAGR), from $2.51M to $1.83M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Summit Therapeutics's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude